Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to preliminarily explore the intervention effect and feasibility of group natural psychotherapy (a new Eastern culture-based psychotherapy method) for patients with anxiety disorder through a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 2, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedApril 8, 2026
March 1, 2026
3 months
April 2, 2026
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Generalized Anxiety Disorder-7 (GAD-7)
The GAD-7 is a brief self-report questionnaire designed to assess the severity of generalized anxiety symptoms (Spitzer et al., 2006). It consists of seven items, with higher scores indicating greater severity of anxiety. Clinical cut-off scores are: 0-4 (minimal/no clinical anxiety), 5-9 (mild), 10-14 (moderate), and ≥ 15 (severe). The Chinese version of the GAD-7 has demonstrated good reliability and validity, with high internal consistency (Cronbach's α = 0.93) and satisfactory test-retest reliability (ICC = 0.71-0.87; Zhang et al., 2021).
week 0; week 4; week 8
State-Trait Anxiety Inventory (STAI)
The STAI consists of two subscales (Spielberger et al., 1970): the State Anxiety Inventory (S-Anxiety, Items 1-20) and the Trait Anxiety Inventory (T-Anxiety, Items 21-40). The S-Anxiety subscale reflects transient feelings of tension, apprehension and nervousness in response to stressors, while the T-Anxiety subscale assesses relatively stable individual differences in anxiety proneness. Both subscales use a 4-point Likert scale (total scores 20-80), with higher scores indicating higher levels of anxiety; certain items are reverse-scored. The Chinese version shows robust reliability and validity, with high internal consistency (Cronbach's α = 0.91-0.92), strong test-retest reliability (0.76-0.91), and significant correlations with the HAMA (r = 0.69-0.74; Ma et al., 2012).
week 0; weeek 4; week 8
Secondary Outcomes (2)
Intolerance of Uncertainty Scale (IUS)
week 0; weeek 4; week 8
Quality of Life Scale (QOL)
week 0; weeek 4; week 8
Other Outcomes (3)
Revised Beads Task
week 0; weeek 4
Emotional Color-word Stroop
week 0; weeek 4
Resting-state functional Magnetic Resonance Imaging (fMRI)
week 0; week 4
Study Arms (2)
Intervention group
EXPERIMENTALParticipants will undergo baseline assessment (T0) prior to the intervention, followed by a 4 week Natural Psychotherapy treatment in group setting. The group therapy will be delivered once per week, with each session lasting 2-3 hours. Post-intervention assessment (T1) will be conducted immediately after the completion of the intervention, and a follow-up assessment will be carried out 1 month after treatment termination (T2).
Waiting-list control group
NO INTERVENTIONParticipants in the control group will receive baseline assessments prior to the waiting period and will continue their treatment-as-usual (TAU) while being placed on a waiting list for 4 weeks. Post-waiting assessment (T1) will be conducted at the end of the waiting period. After T1, the control group patients will receive the same group therapy as the intervention group.
Interventions
Patients will be divided into 3-4 groups, with each group comprising 8-10 patients, led by one psychotherapist. The intervention will last 4 weeks, with all patients required to participate in weekly face-to-face group sessions, each lasting 2-3 hours. The weekly group sessions are the core of the treatment and consists of two parts: (1) phase-specific psychoeducation on the theoretical principles of Natural Psychotherapy; (2) experiential learning through carefully designed activities to facilitate personal experience and understanding of the theoretical content. Homework is assigned after each group session, such as writing treatment diaries and daily exercise plans. The psychotherapists review patients' treatment diaries daily according to guiding principles and provide feedback, offering key guidance and support. Exercise is emphasized as a core component of active action within the Natural Psychotherapy; participants will develop personalized weekly exercise plans during group ses
Eligibility Criteria
You may qualify if:
- Meet the diagnostic criteria for anxiety disorders in the DSM - 5;
- Aged between 15 and 55 years old;
- Have a junior high school education or above;
- The patient agrees to participate in this project and signs the informed consent form.
You may not qualify if:
- Have comorbidities of other severe mental disorders (including schizophrenia, bipolar disorder, and major depressive disorder);
- Have a lifetime history of substance abuse;
- Patients with severe neurological diseases, mental retardation, and cognitive impairment;
- At high risk of suicide or have suicidal behavior;
- Pregnant or breastfeeding;
- Have severe physical diseases and infectious diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Natural Psychotherapy
Hefei, Anhui, 230000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- In the study, primary clinical outcomes were evaluated using self - rating scales.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 2, 2026
First Posted
April 8, 2026
Study Start
March 1, 2026
Primary Completion
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
April 8, 2026
Record last verified: 2026-03